These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30638256)

  • 21. Clinical and genetic studies in patients with Lafora disease from Pakistan.
    Ahmad A; Dad R; Ullah MI; Baig TA; Ahmad IN; Nasir A; Hübner CA; Hassan MJ
    J Neurol Sci; 2017 Feb; 373():263-267. PubMed ID: 28131202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilization of skin biopsy for diagnosis in a case of Lafora disease.
    Rozenova KA; Lehman JS; Grande JP; Fine AL; Wieland CN
    J Cutan Pathol; 2022 Oct; 49(10):885-888. PubMed ID: 35708461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of intracerebroventricular administration of alglucosidase alfa in two mouse models of Lafora disease: Relevance for clinical practice.
    Zafra-Puerta L; Colpaert M; Iglesias-Cabeza N; Burgos DF; Sánchez-Martín G; Gentry MS; Sánchez MP; Serratosa JM
    Epilepsy Res; 2024 Feb; 200():107317. PubMed ID: 38341935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammation in Lafora Disease: Evolution with Disease Progression in Laforin and Malin Knock-out Mouse Models.
    López-González I; Viana R; Sanz P; Ferrer I
    Mol Neurobiol; 2017 Jul; 54(5):3119-3130. PubMed ID: 27041370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trehalose Ameliorates Seizure Susceptibility in Lafora Disease Mouse Models by Suppressing Neuroinflammation and Endoplasmic Reticulum Stress.
    Sinha P; Verma B; Ganesh S
    Mol Neurobiol; 2021 Mar; 58(3):1088-1101. PubMed ID: 33094475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased laforin and laforin binding to glycogen underlie Lafora body formation in malin-deficient Lafora disease.
    Tiberia E; Turnbull J; Wang T; Ruggieri A; Zhao XC; Pencea N; Israelian J; Wang Y; Ackerley CA; Wang P; Liu Y; Minassian BA
    J Biol Chem; 2012 Jul; 287(30):25650-9. PubMed ID: 22669944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deciphering the role of malin in the lafora progressive myoclonus epilepsy.
    Romá-Mateo C; Sanz P; Gentry MS
    IUBMB Life; 2012 Oct; 64(10):801-8. PubMed ID: 22815132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuromuscular junction dysfunction in Lafora disease.
    Shukla M; Chugh D; Ganesh S
    Dis Model Mech; 2024 Oct; 17(10):. PubMed ID: 39301689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laforin in autophagy: a possible link between carbohydrate and protein in Lafora disease?
    Puri R; Ganesh S
    Autophagy; 2010 Nov; 6(8):1229-31. PubMed ID: 20818153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lafora's disease presenting with progressive myoclonus epilepsy].
    Béjot Y; Lemesle-Martin M; Contégal F; Graule-Petot A; Thauvin C; Aubriot-Lorton MH; Moreau T; Giroud M
    Rev Neurol (Paris); 2007 Oct; 163(10):975-8. PubMed ID: 18033035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lafora disease with a fatal outcome].
    Krakhmal NV; Vasilchenko DV; Vtorushin SV
    Arkh Patol; 2022; 84(6):61-66. PubMed ID: 36469720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P-Rex1 is a novel substrate of the E3 ubiquitin ligase Malin associated with Lafora disease.
    Kumarasinghe L; Garcia-Gimeno MA; Ramirez J; Mayor U; Zugaza JL; Sanz P
    Neurobiol Dis; 2023 Feb; 177():105998. PubMed ID: 36638890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endocytosis of the glutamate transporter 1 is regulated by laforin and malin: Implications in Lafora disease.
    Perez-Jimenez E; Viana R; Muñoz-Ballester C; Vendrell-Tornero C; Moll-Diaz R; Garcia-Gimeno MA; Sanz P
    Glia; 2021 May; 69(5):1170-1183. PubMed ID: 33368637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of laforin or malin results in increased Drp1 level and concomitant mitochondrial fragmentation in Lafora disease mouse models.
    Upadhyay M; Agarwal S; Bhadauriya P; Ganesh S
    Neurobiol Dis; 2017 Apr; 100():39-51. PubMed ID: 28063983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of GABAergic cortical neurons underlies the neuropathology of Lafora disease.
    Ortolano S; Vieitez I; Agis-Balboa RC; Spuch C
    Mol Brain; 2014 Jan; 7():7. PubMed ID: 24472629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased endoplasmic reticulum stress and decreased proteasomal function in lafora disease models lacking the phosphatase laforin.
    Vernia S; Rubio T; Heredia M; Rodríguez de Córdoba S; Sanz P
    PLoS One; 2009 Jun; 4(6):e5907. PubMed ID: 19529779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological Interventions to Ameliorate Neuropathological Symptoms in a Mouse Model of Lafora Disease.
    Berthier A; Payá M; García-Cabrero AM; Ballester MI; Heredia M; Serratosa JM; Sánchez MP; Sanz P
    Mol Neurobiol; 2016 Mar; 53(2):1296-1309. PubMed ID: 25627694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lafora disease: a case report.
    Zeka N; Zogaj L; Gerguri A; Bejiqi R; Ratkoceri R; Maloku A; Mustafa A; Shahini L; Maxharaj J
    J Med Case Rep; 2022 Oct; 16(1):360. PubMed ID: 36192771
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.